With some positive early data for an antibody to block the COVID-19 virus, Sorrento Therapeutics Inc. is now looking to test a product in a few dozen intensive care patients by the end of July or early August and move into a much broader pool of patients by October.
VANCOUVER, British Columbia – With some positive early data for an antibody to block the COVID-19 virus, San Diego-based Sorrento Therapeutics Inc. is now looking to test a product in a few dozen intensive care patients by the end of July or early August and move into a much broader pool of patients by October.
HONG KONG – Japan has become the first country in the world to approve Veklury (remdesivir), Gilead Sciences Inc.’s experimental drug, to treat COVID-19. The fast approval was based on U.S. data and that country’s emergency use of the drug to tackle the pandemic, although it is unclear whether the drug is safe or effective for treating COVID-19.
TEL AVIV, Israel – With shares now listed in the U.S. and data from a pivotal trial for its key bladder cancer therapy coming soon, Anchiano Therapeutics Ltd. is poised to ride the wave of interest in gene therapy.
TEL AVIV, Israel – With shares now listed in the U.S. and data from a pivotal trial for its key bladder cancer therapy coming soon, Anchiano Therapeutics Ltd. is poised to ride the wave of interest in gene therapy.
HONG KONG – An Israeli startup has developed a novel solution for bone treatment that allows for both bone repair and drug delivery to address bone conditions. Bonesci Bio Ltd. is now looking to raise several million dollars in a series A round to further develop Peptoss, a peptide known as FFD5 that mimics certain proteins of bone extracellular matrix.
TEL AVIV, Israel – An awakening is underway in the biotech field to develop new products from cannabis, with efforts based on strong science and supported by clinical trials and rigorous research, particularly into the many potential uses of cannabinoids.
TEL AVIV, Israel – The use of digital technologies in medical technology is rapidly moving well beyond efforts to organize data or communicate long distance. Multiple companies are now working to use digital technologies to address medical conditions and improve therapeutic outcomes. While some of these companies are technology companies that have taken something of a back door into health care through consumer products (like the Iwatch or Fitbit that can be used to track metabolic activity or by providing technology platforms like Amazon or Microsoft), other entrants are health care companies first that use digital technology to meet health care goals.
TEL AVIV, Israel – An awakening is underway in the biotech field to develop new products from cannabis, with efforts based on strong science and supported by clinical trials and rigorous research, particularly into the many potential uses of cannabinoids.
